Essential Takeaways
- Conducting a clinical trial isn't necessarily an industry standard. But it's important for us to go above and beyond in illustrating the value of our products.
- And for our first clinical trial, Essential for Women was shown to increase vitamin D levels by 43%, and shown to increase DHA levels by 41%, significantly greater than placebo.*
Huge milestone: Our gold standard clinical study is officially published. Get the full update in our Q&A with Ritual’s VP of Scientific Affairs, Dr. Mastaneh Sharafi, PhD, RD.
Our standard from the very beginning has been to create a multivitamin we ourselves would be proud to take—even if the road to meet that standard would be far from easy.
That’s why completing our first clinical trial was such a big deal: While we have always used evidence-based research to feel confident in our formulas, being able to quantify the impact of Essential for Women 18+ takes us a step further. Completing clinical trials is not always a required industry standard, and demands a significant capital investment that is not always easy for a relatively new business to make. But at Ritual, setting an exceedingly high bar for ourselves is our M.O.—all in the name of helping to make an impact on our customers’ health.*
And it paid off: The results from our 12-week clinical trial—conducted as a double-blind, placebo-controlled trial in a partnership with Auburn University, on 94 women ages 21 through 40—were significant, with Essential for Women 18+ increasing vitamin D3 levels by 43% and omega-3 DHA levels by 41%.*